]>
IRCT20190105042236N1 IRCT 2019-02-10 Esfahan University of Medical Sciences Effect of prophylactic administration of magnesium sulfate on cardiovascular changes during general anesthesia in Gynecologic laparoscopic surgery Effect of prophylactic administration of two doses of magnesium sulfate on cardiovascular changes during general anesthesia in Gynecologic laparoscopic surgery compared with women in the placebo group attending 2016-10-22 anticipated 100 Complete https://irct.ir/trial/36571 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: This study was performed on patients who underwent surgery in Shahid Beheshti and Alzahra Hospitals in Isfahan during the study days as a simple randomized method.So that the syringes of the drug studied by the anesthetist nurse who did not play a role in the data were fill up during the study of the performed surgical operations with a volume of 50 cc(This 50 cc contain 30 cc dose of sulfate or contain 50 cc dose of sulfate or neutral and there was a dose that the injector who was a slave or someone else did not know about this agent), Blinding description: This study was performed on patients who underwent surgery in Shahid Beheshti and Alzahra Hospitals in Isfahan during the study days as a simple randomized method.So that the syringes of the drug studied by the anesthetist nurse who did not play a role in the data were fill up during the study of the performed surgical operations with a volume of 50 cc(This 50 cc contain 30 cc dose of sulfate or contain 50 cc dose of sulfate or neutral and there was a dose that the injector who was a slave or someone else did not know about this agent). 2-3 Effect of prophylactic administration of two doses of magnesium sulfate on cardiovascular changes during general anesthesia in Gynecologic laparoscopic surgery. Intervention 1: Intervention group: Magnesium sulfate at a dose of 30 mg / kg. Intervention 2: Intervention group: Magnesium sulfate at a dose of 50 mg / kg. Intervention 3: Control group: Without getting magnesium sulfat. Yes - There is a plan to make this available What will be shared: All personal information can be provided after the name is deleted When: Start access after posting the related article after 1398 To whom: Researchers working in academia and academia Conditions: To develop this study Where to obtain: Email me. m43.mostashfi@gmail.com How to obtain: Data is provided after examining the individual's request and ensuring proper use and insertion of the data source Comments:
public Mona Mostashfi
No.15, Keihan ALye, Bisim Ave, Isfahan
Isfahan Iran (Islamic Republic of) 8157764863 +98 31 3267 9440 amirmostashfi@gmail.com Esfahan University of Medical Sciences scientific Mona Mostashfi
No.15, Keihan ALye, Bisim Ave, Isfahan
Isfahan Iran (Islamic Republic of) 8157764863 +98 31 3267 9440 amirmostashfi@gmail.com Esfahan University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Patients ASA 1 Patients ASA 2 Women Laparoscopic Surgery Outer uterus and endometriosis and diagnosis (infertility) Maximum operating time is 150 minutes no limit no limit Female High blood pressure Sensitization to magnesium sulfate Heart block Emergency situation E61.2 Magnesium deficiency Prevention Prevention Prevention Intervention group: Magnesium sulfate at a dose of 30 mg / kg Intervention group: Magnesium sulfate at a dose of 50 mg / kg Control group: Without getting magnesium sulfat Change of systolic blood pressure. Timepoint: before the induction of anesthesia as a base and after the anesthesia were measured and recorded after the finishing of the infused medication. These parameters were measured and recorded immediately before the pneumoperitoneum and 5, 10, 20, 30,40 minutes After pneumoperitoneum. Method of measurement: Barometer. Change of heart rate. Timepoint: before the induction of anesthesia as a base and after the anesthesia were measured and recorded after the finishing of the infused medication. These parameters were measured and recorded immediately before the pneumoperitoneum and 5, 10, 20, 30,40 minutes After pneumoperitoneum. Method of measurement: Pulse oximeter. The amount of chills and vomiting. Timepoint: After the recovery. Method of measurement: Objective observation and question. Esfahan University of Medical Sciences Approved 2016-04-17 Ethics Committee of Isfahan Medical School Alzahra Hospital, Sofeh Blvd, Isfahan Province, Isfahan Isfahan Isfehan Iran (Islamic Republic of)